A new Senate bill is being filed that would promote research into the therapeutic potential psychedelics, aiming to create a new office in the Department of Veterans Affairs (VA) that would advance the development innovative treatments for serious mental health conditions and assist in reviewing the scheduling status of drugs like psilocybin, ibogaine and MDMA.<\/p>\n
The legislation\u2014titled the \u201cVeterans Health Administration Novel Therapeutics Preparedness Act\u201d\u2014is being sponsored by Sen. Tim Sheehy (R-MT). It would direct the VA to take steps to streamline studies into psychedelics and other emerging therapies, according to bill text obtained by Marijuana Moment.<\/p>\n
This is one of the latest examples of congressional efforts to encourage scientific investigations into psychedelics, with a focus on military veterans with conditions such as post-traumatic stress disorder (PTSD), treatment-resistant depression, substance use disorder, traumatic brain injury (TBI), chronic pain and more.<\/p>\n
The bill is expected to be formally filed on Wednesday, according to a source familiar with the planning. Marijuana Moment reached out to Sheehy\u2019s office for comment, but a representative was not immediately available.<\/p>\n
\u201cEmerging therapeutic interventions, including certain psychedelic-assisted therapies under evaluation by the Food and Drug Administration as of the date of the enactment of this Act, may significantly alter the treatment landscape for post-traumatic stress disorder, depression, and other mental health conditions affecting veterans,\u201d a findings section of the bill says.<\/p>\n
\u201cThe administration of certain emerging therapies may require intensive clinical engagement, interdisciplinary teams, dedicated clinical space, structured preparation, and post-treatment integration that differ substantially from traditional outpatient mental health services,\u201d it continues, adding that VA is \u201cuniquely positioned to deliver integrated, veteran-centered care that combines medical, mental health, and peer support services within a single system of care.\u201d<\/p>\n
That\u2019s the only explicit mention of \u201cpsychedelics\u201d in the legislation, and it doesn\u2019t list specific psychedelic substances that would be prioritized for research, but that\u2019s a common feature of recently filed bills touching on the issue, with various other examples using catchall terminology like innovative or novel treatments or therapies effectively serving as a stand-in for \u201cpsychedelics.\u201d<\/p>\n
Under the measure, a new Office of Novel Therapeutics would be established under the Veterans Health Administration (VHA) to facilitate the research initiatives. Studies exploring the alternative treatments would focus on substances such as psychedelics that are under review for potential approval by the Food and Drug Administration (FDA).<\/p>\n
\u201cAbsent centralized governance and implementation planning, the Department may face delays, safety risks, or inconsistent access following regulatory approval of such therapies,\u201d the bill\u2019s findings section says. \u201cEstablishing a dedicated Office of Novel Therapeutics will ensure that the Department is prepared to responsibly evaluate, research, and implement emerging treatment modalities consistent with patient safety and evidence-based practice.\u201d<\/p>\n
There would be at least one \u201cCenter of Excellence\u201d to facilitate the program in each VA regional district to help develop a national model for the initiative. A Veteran Advisory Committee would be established, comprised of veterans, experts and health professionals, to advise on matters such as access barriers and safety protocols.<\/p>\n
VA would also need to coordinate with other federal agencies\u2014including the U.S. Department of Health and Human Services (HHS), FDA, Centers for Medicaid & Medicare Services (CMS), the Department of Defense (DOD) and Drug Enforcement Administration (DEA)\u2014to consider regulatory issues, possible rescheduling action for novel therapies and means of providing health care coverage for psychedelics access and treatment.<\/p>\n
VA would need to furnish annual reports to Congress updating lawmakers on its progress. Within 180 days of the bill\u2019s enactment, the department would need to report on practical considerations such as staffing needs and regulatory barriers.<\/p>\n
The bill is somewhat similar in intent to another bipartisan measure filed earlier this month<\/a>, sponsored by Sens. Ruben Gallego (D-AZ) and David McCormick (R-PA), that would provide $30 million in funding annually to establish psychedelic-focused \u201ccenters for excellence\u201d at VA facilities, where veterans could receive novel treatment involving substances like psilocybin, MDMA and ibogaine.<\/p>\n A House companion version of the bill\u2014sponsored by Congressional Psychedelics Advancing Therapies (PATH) Caucus co-chairs<\/a>\u00a0Reps. Lou Correa (D-CA) and Jack Bergman (R-MI)\u2014was introduced last year, but it has not yet advanced in the chamber. The House and Senate measures are substantively identical, with minor formatting differences.<\/p>\n Lawmakers and advocates supporting such reform bills notably have allies in top positions within the Trump administration, including VA Secretary Doug Collins and HHS Secretary Robert F. Kennedy, Jr. who have both embraced psychedelic policy reform.<\/p>\n Kennedy recently told Joe Rogan on a podcast episode that\u00a0the administration is \u201cvery anxious\u201d to create a pathway for the novel therapies<\/a>\u00a0and that officials across federal agencies want to \u201cget it out to the public as quickly as possible.\u201d<\/p>\n Multiple veterans groups also recently advised congressional lawmakers about the need to\u00a0continue exploring psychedelics and marijuana as alternative treatment options<\/a>\u00a0for the military veteran population at hearings on Capitol Hill. The Wounded Warrior Project (WWP) and Veterans of Foreign Wars (VFW) specifically cited the Innovative Therapies Centers of Excellence Act as an example of a reform they\u2019re backing.<\/p>\n Correa and Bergman, the House sponsors of that legislation, separately filed a bill in January that would\u00a0also promote research into the therapeutic potential of certain psychedelics<\/a>\u00a0in the treatment of serious mental health conditions experienced by veterans.<\/p>\n The bipartisan duo in January also\u00a0discussed\u00a0the importance of strategically advancing psychedelics reform<\/a>\u00a0in a way that mitigates bureaucratic conflict and the influence of outside interests. Even just one misstep could threaten to upend the movement, they said.<\/p>\n Last year, the VA secretary\u00a0touted his role in promoting psychedelics access for veterans<\/a>\u00a0with serious mental health conditions, saying he \u201copened that door probably wider than most ever thought\u201d was possible. The department in 2024\u00a0faced criticism after rejecting a grant application from an organization that\u00a0helps connect veterans to programs abroad where they can receive psychedelic therapy<\/a>\u00a0to treat serious mental health conditions.<\/p>\n Meanwhile, in November, Kennedy, Vice President JD Vance, the FDA commissioner and other Trump administration officials attended a \u201cMake America Healthy Again\u201d summit that\u00a0featured a session dedicated to exploring psychedelic medicine<\/a>.<\/p>\n In June, Kennedy said his agency is\u00a0\u201cabsolutely committed\u201d to expanding research on the benefits of psychedelic therapy<\/a>\u00a0and, alongside of the head of FDA, is aiming to provide legal access to such substances for military veterans \u201cwithin 12 months.\u201d<\/p>\n The secretary also said in April that\u00a0he had a \u201cwonderful experience\u201d with LSD at 15 years old<\/a>, which he took because he thought he\u2019d be able to see dinosaurs, as portrayed in a comic book he was a fan of.<\/p>\n Last October, Kennedy specifically criticized FDA under the prior administration over the agency\u2019s \u201csuppression of psychedelics\u201d and a laundry list of other issues that he said amounted to a \u201cwar on public health\u201d that would end under the Trump administration.<\/p>\n Read the text<\/a> of the Veterans Health Administration Novel Therapeutics Preparedness Act below:<\/strong><\/p>\n\n The post GOP Senator To File Bill Promoting Psychedelics Research And Treatment For Veterans<\/a> appeared first on Marijuana Moment<\/a>.<\/p>\n
A new Senate bill is being filed that would promote research into the therapeutic potential psychedelics, aiming to create a new office in the Department of Veterans Affairs (VA) that would advance the development innovative treatments for serious mental health conditions and assist in reviewing the scheduling status of drugsContinue Reading<\/a><\/span><\/p>\n","protected":false},"author":458,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[18,81],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/85692"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/458"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=85692"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/85692\/revisions"}],"predecessor-version":[{"id":85693,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/85692\/revisions\/85693"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=85692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=85692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=85692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n
\nRead More: GOP Senator To File Bill Promoting Psychedelics Research And Treatment For Veterans<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"